vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and CPI Card Group Inc. (PMTS). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $153.1M, roughly 1.3× CPI Card Group Inc.). CPI Card Group Inc. runs the higher net margin — 4.8% vs -14.6%, a 19.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 22.3%). CPI Card Group Inc. produced more free cash flow last quarter ($35.2M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 16.9%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
CPI Card Group Inc. is a leading provider of payment card production and associated solutions, including contactless and contact credit/debit cards, prepaid cards, and card personalization services. It primarily serves financial institutions, fintech firms, and retail brands across its core North American market.
AXSM vs PMTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $153.1M |
| Net Profit | $-28.6M | $7.3M |
| Gross Margin | — | 31.5% |
| Operating Margin | -13.8% | 12.0% |
| Net Margin | -14.6% | 4.8% |
| Revenue YoY | 65.0% | 22.3% |
| Net Profit YoY | 61.9% | 8.5% |
| EPS (diluted) | $-0.55 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $153.1M | ||
| Q3 25 | $171.0M | $138.0M | ||
| Q2 25 | $150.0M | $129.8M | ||
| Q1 25 | $121.5M | $122.8M | ||
| Q4 24 | $118.8M | $125.1M | ||
| Q3 24 | $104.8M | $124.8M | ||
| Q2 24 | $87.2M | $118.8M | ||
| Q1 24 | $75.0M | $111.9M |
| Q4 25 | $-28.6M | $7.3M | ||
| Q3 25 | $-47.2M | $2.3M | ||
| Q2 25 | $-48.0M | $518.0K | ||
| Q1 25 | $-59.4M | $4.8M | ||
| Q4 24 | $-74.9M | $6.8M | ||
| Q3 24 | $-64.6M | $1.3M | ||
| Q2 24 | $-79.3M | $6.0M | ||
| Q1 24 | $-68.4M | $5.5M |
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 29.7% | ||
| Q2 25 | — | 30.9% | ||
| Q1 25 | — | 33.2% | ||
| Q4 24 | — | 34.1% | ||
| Q3 24 | — | 35.8% | ||
| Q2 24 | — | 35.7% | ||
| Q1 24 | — | 37.1% |
| Q4 25 | -13.8% | 12.0% | ||
| Q3 25 | -27.0% | 9.4% | ||
| Q2 25 | -24.5% | 7.3% | ||
| Q1 25 | -46.9% | 11.5% | ||
| Q4 24 | -61.1% | 12.7% | ||
| Q3 24 | -59.8% | 14.3% | ||
| Q2 24 | -89.5% | 12.5% | ||
| Q1 24 | -89.7% | 12.6% |
| Q4 25 | -14.6% | 4.8% | ||
| Q3 25 | -27.6% | 1.7% | ||
| Q2 25 | -32.0% | 0.4% | ||
| Q1 25 | -48.9% | 3.9% | ||
| Q4 24 | -63.1% | 5.4% | ||
| Q3 24 | -61.7% | 1.0% | ||
| Q2 24 | -91.0% | 5.1% | ||
| Q1 24 | -91.1% | 4.9% |
| Q4 25 | $-0.55 | $0.62 | ||
| Q3 25 | $-0.94 | $0.19 | ||
| Q2 25 | $-0.97 | $0.04 | ||
| Q1 25 | $-1.22 | $0.40 | ||
| Q4 24 | $-1.54 | $0.56 | ||
| Q3 24 | $-1.34 | $0.11 | ||
| Q2 24 | $-1.67 | $0.51 | ||
| Q1 24 | $-1.44 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $21.7M |
| Total DebtLower is stronger | — | $286.7M |
| Stockholders' EquityBook value | $88.3M | $-17.3M |
| Total Assets | $689.8M | $403.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $21.7M | ||
| Q3 25 | $325.3M | $16.0M | ||
| Q2 25 | $303.0M | $17.1M | ||
| Q1 25 | $300.9M | $31.5M | ||
| Q4 24 | $315.4M | $33.5M | ||
| Q3 24 | $327.3M | $14.7M | ||
| Q2 24 | $315.7M | $7.5M | ||
| Q1 24 | $331.4M | $17.1M |
| Q4 25 | — | $286.7M | ||
| Q3 25 | — | $308.4M | ||
| Q2 25 | — | $310.9M | ||
| Q1 25 | — | $280.7M | ||
| Q4 24 | — | $280.4M | ||
| Q3 24 | — | $280.2M | ||
| Q2 24 | — | $269.7M | ||
| Q1 24 | — | $265.3M |
| Q4 25 | $88.3M | $-17.3M | ||
| Q3 25 | $73.7M | $-25.7M | ||
| Q2 25 | $73.1M | $-29.0M | ||
| Q1 25 | $53.2M | $-29.7M | ||
| Q4 24 | $57.0M | $-35.6M | ||
| Q3 24 | $92.9M | $-42.8M | ||
| Q2 24 | $102.9M | $-44.6M | ||
| Q1 24 | $144.0M | $-48.5M |
| Q4 25 | $689.8M | $403.2M | ||
| Q3 25 | $669.3M | $407.1M | ||
| Q2 25 | $639.8M | $399.8M | ||
| Q1 25 | $596.7M | $351.9M | ||
| Q4 24 | $568.5M | $349.7M | ||
| Q3 24 | $561.5M | $342.3M | ||
| Q2 24 | $548.2M | $321.4M | ||
| Q1 24 | $545.7M | $319.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $39.6M |
| Free Cash FlowOCF − Capex | $-18.7M | $35.2M |
| FCF MarginFCF / Revenue | -9.6% | 23.0% |
| Capex IntensityCapex / Revenue | 0.0% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 5.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $41.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $39.6M | ||
| Q3 25 | $1.0M | $10.0M | ||
| Q2 25 | $-32.4M | $4.3M | ||
| Q1 25 | $-43.4M | $5.6M | ||
| Q4 24 | $-26.2M | $26.7M | ||
| Q3 24 | $-18.6M | $12.5M | ||
| Q2 24 | $-30.1M | $-4.8M | ||
| Q1 24 | $-53.5M | $8.9M |
| Q4 25 | $-18.7M | $35.2M | ||
| Q3 25 | $988.0K | $5.3M | ||
| Q2 25 | $-32.4M | $533.0K | ||
| Q1 25 | $-43.7M | $292.0K | ||
| Q4 24 | $-26.2M | $21.6M | ||
| Q3 24 | $-18.7M | $11.1M | ||
| Q2 24 | $-30.2M | $-6.0M | ||
| Q1 24 | $-53.6M | $7.4M |
| Q4 25 | -9.6% | 23.0% | ||
| Q3 25 | 0.6% | 3.8% | ||
| Q2 25 | -21.6% | 0.4% | ||
| Q1 25 | -36.0% | 0.2% | ||
| Q4 24 | -22.1% | 17.3% | ||
| Q3 24 | -17.9% | 8.9% | ||
| Q2 24 | -34.6% | -5.0% | ||
| Q1 24 | -71.4% | 6.6% |
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 3.4% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.3% | 4.3% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.0% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | — | 5.39× | ||
| Q3 25 | — | 4.32× | ||
| Q2 25 | — | 8.39× | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | 3.94× | ||
| Q3 24 | — | 9.70× | ||
| Q2 24 | — | -0.79× | ||
| Q1 24 | — | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
PMTS
| US Debit And Credit | $128.9M | 84% |
| US Prepaid Debit | $24.4M | 16% |
